InvestorsHub Logo
Followers 275
Posts 32725
Boards Moderated 0
Alias Born 11/14/2013

Re: flipper44 post# 666217

Wednesday, 02/28/2024 1:18:47 PM

Wednesday, February 28, 2024 1:18:47 PM

Post# of 703907
Follow up to Hoffman’s INN USAN due diligence.

Hoffman predicted USAN adopted name (Murcidencel) publication for end of January 2024 based on last year’s successful INN review timing.

USAN publication has not occurred yet, and since companies are allowed to ask for up to a six month deferral on publication, I assume that’s what NWBO did. How much of that six month deferral they’d want, I do not hazard a guess.

Why would they do this? I also won’t hazard a guess other than to say they could use the name as far back as November 29, 2023, based upon successful INN review, according to Hoffman, so I assume they probably used it to some degree in the MHRA maa filing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News